Welcome to the Bioasis Technologies Hub On AGORACOM

Free
Message: Finally some news

Wouldn't Janssen need to prove the human safety aspect first of the Bioasis proprietary xB3TM platform technology for the delivery of therapeutics across the blood-brain barrier before anything else going forward?

 

Koo

Share
New Message
Please login to post a reply